Hyperinsulinaemic hypoglycaemia caused by over functioning beta cells is a potentially lethal disease especially to infants. Our highly-innovative integrated therapy platform will allow diagnosis and guide therapeutic intervention.
Hyperinsulinaemic hypoglycaemia caused by over functioning beta cells is a potentially lethal disease especially to infants. Our highly-innovative integrated therapy platform will allow diagnosis and guide therapeutic intervention.
© 2020 BetaCure Legal Disclaimer
 |
This project has received funding from the European Union’s Seventh Framework Programme for research, technological development and demonstration under grant agreement no 602812. This website reflects only the authors' view and the European Commission is not responsible for any use that may be made of the information it contains. |